Literature DB >> 11281572

Duration of immunosuppressive therapy in autoimmune hepatitis.

S Kanzler, G Gerken, H Löhr, P R Galle, K H Meyer zum Büschenfelde, A W Lohse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11281572     DOI： 10.1016/s0168-8278(00)00095-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  21 in total

1.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 2.  Current concepts in the diagnosis and management of autoimmune hepatitis.

Authors:  Stephen Kriese; Michael A Heneghan
Journal:  Frontline Gastroenterol       Date:  2012-11-12

Review 3.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 4.  Challenges in the diagnosis and management of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Can J Gastroenterol       Date:  2013-09       Impact factor: 3.522

5.  Psychological stress is associated with relapse in type 1 autoimmune hepatitis.

Authors:  Savita Srivastava; James L Boyer
Journal:  Liver Int       Date:  2010-09-16       Impact factor: 5.828

Review 6.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

7.  Treatment of Autoimmune Hepatitis: Current and Future Therapies.

Authors:  Fernando Alvarez
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

Review 8.  Update on autoimmune hepatitis.

Authors:  Andreas Teufel; Peter R Galle; Stephan Kanzler
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

9.  The use of budesonide in the treatment of autoimmune hepatitis in Canada.

Authors:  Iman Zandieh; Darin Krygier; Victor Wong; John Howard; Lawrence Worobetz; Gerald Minuk; Helga Witt-Sullivan; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522

10.  Long-term treatment outcomes for autoimmune hepatitis in Korea.

Authors:  Jae Sook Kil; Joon Hyoek Lee; A-Reum Han; Ja Young Kang; Hye Jin Won; Han Young Jung; Hyun Min Lim; Geum-Youn Gwak; Moon Seok Choi; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  J Korean Med Sci       Date:  2009-12-29       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.